VKTX Viking Therapeutics Inc

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.

$6.64  +0.09 (1.30%)
As of 03/05/2021 15:59:47 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
04/29/2015
74,133,121
1,783,304
$485,571,943
0.00%
SEC Edgar Online
10-Q
10-K
92686J106
US92686J1060
BQQG1V1

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
1.67
0.00
-16.16%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy